Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 11, 2013
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has received formal approval from the U.S. Food and Drug Administration (FDA) of its supplemental filing for the site transfer of ...
read more
The Russian pharmaceutical market is developing rapidly; it takes 11th place in the rating of pharmaceutical market volumes worldwide and is predicted to go up to 9th place by 2016. Along with its growing potential, important changes in the industry ...
read more
Thursday, January 29, 2026
WuXi Biologics and Sinorda Biomedicine announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific antibody, for the potential treatment of inflammatory bowel disease (IBD) and other autoimmune diseases.
read more
Wednesday, September 10, 2025
BioIVT announced the company is expanding with new office space and a laboratory facility in Woodbury, New York.
read more
Wednesday, August 24, 2016
Mallinckrodt has entered into a definitive agreement under which it will sell its Nuclear Imaging business to IBA Molecular (IBAM), for approximately $690 million before tax impacts, including up-front and contingent consideration and the assumption ...
read more
Monday, December 19, 2016
Pharma Tech Industries has introduced a new high-speed bottling line for the production of Rx, OTC and nutritional ingestible products at its Union, MO facility.
read more
Neuland Laboratories has brought online a fully operational dedicated Process Engineering Lab at its R&D Center.
read more
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced a multi-year investment in its global hydration capabilities. The ...
read more
Premier Research announced the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) Leadership Team.
read more
Tuesday, December 10, 2019
Quantum Genomics and Biolab Sanus have entered into an exclusive licensing and collaboration agreement to develop and commercialize firibastat in Latin America.
read more
BioDuro has broadly launched new antibody- and cell-based therapy discovery services.
read more
Wednesday, August 04, 2021
DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, a global provider of advanced delivery technologies...
read more
Wednesday, August 19, 2015
Boehringer Ingelheim has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for an update to the European label for Giotrif®.
read more
Thursday, September 13, 2018
Cambrex has completed the acquisition of Halo Pharma, a dosage form CDMO located in Whippany, New Jersey and Mirabel, Québec, Canada, for approximately $425 million.
read more
Thursday, December 18, 2025
ClinTrial Research (CTR) announced that it has closed a growth equity round led by Tarsadia Investments, a multi-billion-dollar firm that makes high-conviction investments in category-defining companies globally. The investment reflects Tarsadia's ...
read more